Protagonist Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $8.82 billion, with shareholders equity totaling $1.08 billion.
The company employs approximately 79 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Protagonist Therapeutics Inc. reported $551.69 million in revenue, generating net income of $342.26 million.
Key financial metrics include a P/E ratio of 25.77, a price-to-book (P/B) ratio of 8.13, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker PTGX.